Haohan Tan

This inventor holds 14 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 11 EPO patents. Top assignees: Shanghai Fochon Pharmaceutical Co., Ltd., Fochon Pharmaceuticals, Ltd., Chinese Academy of Sciences. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haohan Tan. Retrieved from https://idiyas.com/inventor/haohan-tan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 5)

% Patents Active = 71.4

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 14.7

ph-index = 1

Forward Citations = 10(Granted Patents)

Location History:

Chongqin, CN (2017)
Chongqing, CN (2015 - 2023)

Company Filing History:

9 out of 13

Shanghai Fochon Pharmaceutical Co., Ltd.

patents

5 out of 7

Fochon Pharmaceuticals, Ltd.

patents

2 out of 3,363

Chinese Academy of Sciences

patents

4. 2 out of 3

Chongqing Fochon Pharmaceutical Co., Ltd.

patents

5. 2 out of 2

Fochon Biosciences, Ltd.

patents

6. 1 out of 1

Fochon Pharmaceutical Co., Ltd.

patent

7. 1 out of 4

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312349 - Apoptosis-inducing agents (2025-05-27),

2. 11555042 - Macrocyclic compounds as TRK kinases inhibitors (2023-01-17),

3. 11459332 - Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors (2022-10-04),

4. 11168078 - Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase (2021-11-09),

5. 11091478 - Apoptosis-inducing agents (2021-08-17),

6. 11053239 - Compounds as BLC-2-selective apoptosis-inducing agents (2021-07-06),

7. 10894038 - Indolizine derivatives, composition and methods of use (2021-01-19),

8. 10800785 - Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitors (2020-10-13),

9. 10450316 - Certain protein kinase inhibitor (2019-10-22),

10. 10087195 - Certain protein kinase inhibitors (2018-10-02),

11. 10022374 - Certain protein kinase inhibitors (2018-07-17),

12. 9567342 - Certain protein kinase inhibitors (2017-02-14),

13. 9556171 - Certain protein kinase inhibitors (2017-01-31),

14. 9206166 - Certain protein kinase inhibitors (2015-12-08),

Title: Haohan Tan - Innovative Inventor from Chongqing

Introduction: Haohan Tan is a renowned inventor hailing from Chongqing, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Haohan Tan holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating solutions for the future.

Career Highlights: Throughout his career, Haohan Tan has worked with leading research institutions and technology companies to develop cutting-edge products that have revolutionized various industries. His expertise in merging technology with sustainability has earned him recognition globally.

Collaborations: Haohan Tan has collaborated with top universities and multinational corporations to further his research and bring his inventions to the market. His collaborative efforts have resulted in the successful implementation of innovative solutions in real-world scenarios.

Conclusion: Haohan Tan's passion for innovation and his dedication to creating a sustainable future through technology make him a standout figure in the world of inventors. His work continues to inspire and drive progress in the ever-evolving landscape of technology and innovation.

Profile summary based on public USPTO records.